Who Paid My Doc
Maria Paricio
Geriatric Psychiatry South Miami, FL Medical Doctor
NPI 1104868538 CMS profile 185830
7325 Sw 63Rd Ave, Suite 201, South Miami, FL 33143
General payments
$483
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$498,884
Through program year 2019, Maria Paricio of South Miami, FL is reported in the CMS Open Payments database as having received $483 across 3 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $498,884 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 58th percentile of Geriatric Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $483 | 3 |
Beside peers
- Maria Paricio
- Geriatric Psychiatry median
- Middle half of Geriatric Psychiatry
- National median
In program year 2025, general payments to Maria Paricio were reported at $0. Among 188 Geriatric Psychiatry profiles paid that year, the median was $125 and the middle half received between $52 and $515.
Show as a table
| Year | Maria Paricio | Geriatric Psychiatry median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $483 | $151 | $47–$484 | $163 |
| 2020 | $0 | $112 | $30–$410 | $114 |
| 2021 | $0 | $122 | $35–$550 | $132 |
| 2022 | $0 | $133 | $54–$557 | $149 |
| 2023 | $0 | $138 | $61–$485 | $160 |
| 2024 | $0 | $127 | $51–$572 | $164 |
| 2025 | $0 | $125 | $52–$515 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 20 drugsPart D claims
1,638
Drug cost
$29,706
Branded share of claims
4.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Quetiapine Fumarate | Generic | 350 | $5,972 | |
| Lorazepam | Generic | 247 | $2,736 | |
| Temazepam | Generic | 183 | $2,439 | |
| Olanzapine | Generic | 72 | $2,021 | |
| Quetiapine Fumarate Er Quetiapine Fumarate | Brand | 34 | $1,681 | |
| Divalproex Sodium | Generic | 16 | $1,576 | |
| Alprazolam | Generic | 122 | $1,538 | |
| Triazolam | Generic | 21 | $1,514 | |
| Clonazepam | Generic | 179 | $1,438 | |
| Escitalopram Oxalate | Generic | 99 | $1,364 |
The 10 drugs with the highest cost, of 20 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 10 billing codesPaid by Medicare
$64,678
Medicare patients
480
Services billed
830
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Alzheimer's or dementia | 75% | |
| Depression | 68% | |
| Arthritis | 68% | |
| Diabetes | 55% | |
| Ischemic heart disease | 51% | |
| Heart failure | 46% | |
| Chronic kidney disease | 43% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
3 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Geriatric Psychiatry in Florida
Related records
Geriatric Psychiatry in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Geriatric Psychiatry
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.